Rhythm Pharmaceuticals's total assets for Q4 2024 were $392.27M, an increase of 7.89% from the previous quarter. RYTM total liabilities were $227.72M for the fiscal quarter, a -35.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.